Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on Mitapivat
– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult…
Fobi AI Provides Update on Current Cease Trade Order
December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British…
Fobi AI Provides Update on Current Cease Trade Order
December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British…
BitFuFu Announces November 2024 Production and Mining Operations Update
December 06, 2024 06:00 ET | Source: BitFuFu Inc. ● 1,643 BTC…
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif.,…
Bitdeer Announces November 2024 Production and Operations Update
- Anticipated ~35 EH/s of SEALMINER A2 Mass Production through Q3 2025 -…
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment…
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
November 26, 2024 01:30 ET | Source: ONWARD Medical NV Raised EUR…